A Phase 3, Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Study of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis
收藏DataCite Commons2025-10-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00003063/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
Study of the efficacy and safety of adalimumab compared with placebo in adult Chinese participants with ankylosing spondylitis (AS) who have had an inadequate response to or who are intolerant to one or more nonsteroidal anti-inflammatory drugs (NSAIDs)
提供机构：
Vivli
创建时间：
2018-10-27
